FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 143 filers reported holding FLEXION THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $128,112,000 | -2.9% | 21,002 | +31.0% | 0.00% | – |
| Q2 2021 | $131,910,000 | -36.1% | 16,028 | -30.5% | 0.00% | – |
| Q1 2021 | $206,360,000 | +262.4% | 23,057 | +367.2% | 0.00% | – |
| Q4 2020 | $56,950,000 | -45.9% | 4,935 | -51.2% | 0.00% | – |
| Q3 2020 | $105,276,000 | +62.0% | 10,113 | +104.7% | 0.00% | – |
| Q2 2020 | $64,974,000 | -57.9% | 4,941 | -74.8% | 0.00% | – |
| Q1 2020 | $154,346,000 | +88.8% | 19,612 | +396.5% | 0.00% | – |
| Q4 2019 | $81,765,000 | +11.5% | 3,950 | -26.2% | 0.00% | – |
| Q3 2019 | $73,349,000 | +58.6% | 5,352 | +42.4% | 0.00% | – |
| Q2 2019 | $46,236,000 | -47.0% | 3,759 | -46.2% | 0.00% | – |
| Q1 2019 | $87,273,000 | +59269.4% | 6,993 | +53692.3% | 0.00% | – |
| Q4 2018 | $147,000 | -99.3% | 13 | -98.8% | 0.00% | – |
| Q3 2018 | $20,768,000 | -29.3% | 1,110 | -2.4% | 0.00% | – |
| Q2 2018 | $29,391,000 | -80.7% | 1,137 | -83.3% | 0.00% | – |
| Q1 2018 | $152,209,000 | -10.1% | 6,792 | +0.5% | 0.00% | – |
| Q4 2017 | $169,270,000 | +153.7% | 6,760 | +145.0% | 0.00% | – |
| Q3 2017 | $66,713,000 | +11.8% | 2,759 | -6.5% | 0.00% | – |
| Q2 2017 | $59,669,000 | +1879.7% | 2,951 | +2534.8% | 0.00% | – |
| Q1 2017 | $3,014,000 | -64.0% | 112 | -74.5% | 0.00% | – |
| Q4 2016 | $8,369,000 | -73.3% | 440 | -72.6% | 0.00% | – |
| Q3 2016 | $31,362,000 | +185.6% | 1,605 | +118.7% | 0.00% | – |
| Q2 2016 | $10,981,000 | -79.4% | 734 | -73.4% | 0.00% | – |
| Q4 2015 | $53,262,000 | +15.8% | 2,764 | -10.7% | 0.00% | – |
| Q3 2015 | $45,977,000 | +81.5% | 3,094 | +167.4% | 0.00% | – |
| Q2 2015 | $25,327,000 | +649.8% | 1,157 | +671.3% | 0.00% | – |
| Q1 2015 | $3,378,000 | -60.1% | 150 | -67.7% | 0.00% | – |
| Q3 2014 | $8,473,000 | +61.6% | 464 | +19.3% | 0.00% | – |
| Q2 2014 | $5,244,000 | – | 389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|